Peter Humphreys Archives - Compliance Podcast Network

GSK In China: 13 Years Later – After the Humphreys Verdict: Managing Third-Party Risk When You Can’t Verify

Thirteen years after the GSK China scandal exploded onto the global stage, its lessons remain as urgent as ever for compliance professionals and business leaders. In this podcast series, we revisit the case not simply as corporate history, but as a living cautionary tale about culture, incentives, third parties, investigations, and governance. Each episode explores what went wrong, why it went wrong, and how those failures still echo in today’s compliance and ethics landscape. Join me as we unpack the scandal and draw practical lessons for building stronger, more resilient organizations. In this episode, we take a deep dive into the 2013 GSK China bribery scandal and examine why it remains one of the most important case studies in corporate compliance, governance, and culture. Our hosts are Timothy and Fiona.

The episode examines how multinational companies should manage third-party relationships and compliance in opaque markets like China when traditional intelligence-gathering is curtailed by privacy laws, using the case of corporate investigators Peter Humphreys and his wife Ying Zeng, who were hired by GSK to investigate a sex-tape scandal but were convicted and imprisoned for purchasing Chinese citizens’ personal data. The discussion highlights how the verdict created operational uncertainty for due diligence, M&A, supplier vetting, and anti-bribery efforts, and notes Humphrey’s claim that GSK withheld the fact that it faced internal whistleblower allegations of corruption. Drawing on DOJ expectations and an SCCE framework, it argues for shifting from “vet and forget” to continuous third-party management across five steps, reinforcing business justification, questionnaires, contracts, and ongoing oversight with mitigations like capped commissions, detailed invoice review, early audits, and use of public records and in-person interviews.